GODEX + Placebo
Phase 3Recruiting 2 views this week 0 watching⚡ Active
Interest: 47/100
47
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Non-Alcoholic Fatty Liver Disease
Conditions
Non-Alcoholic Fatty Liver Disease
Trial Timeline
Sep 25, 2023 → Feb 26, 2027
NCT ID
NCT06152991About GODEX + Placebo
GODEX + Placebo is a phase 3 stage product being developed by Celltrion for Non-Alcoholic Fatty Liver Disease. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06152991. Target conditions include Non-Alcoholic Fatty Liver Disease.
What happened to similar drugs?
0 of 3 similar drugs in Non-Alcoholic Fatty Liver Disease were approved
Approved (0) Terminated (0) Active (3)
Hype Score Breakdown
Clinical
17
Activity
15
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06152991 | Phase 3 | Recruiting |
Competing Products
20 competing products in Non-Alcoholic Fatty Liver Disease